A 15-year-old female with focal seizures is poorly controlled on levetiracetam. The clinician wants to add an agent that is least likely to have significant pharmacokinetic interactions with her current medication or require dose adjustments based on enzyme induction or inhibition. Which of the following is exclusively excreted by the kidney and would fit this requirement?